$NKTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEKTAR THERAPEUTICS. Get notifications about new insider transactions in NEKTAR THERAPEUTICS for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2007 | NKTR | NEKTAR THERAPEUTIC ... | Elam Nevan C | SVP, Head Pulmonary ... | Grant | A | 0.01 | 1,400 | 14 | 1,400 | 0 to 1.4 K |
| May 14 2007 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Grant | A | 12.15 | 1,000 | 12,150 | 6,000 | 5 K to 6 K (+20.00 %) |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Option Exercise | A | 13.02 | 40,000 | 520,800 | 130,000 | |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | A | 13.02 | 30,000 | 390,600 | 162,800 | |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | Elam Nevan C | VP, Pulmonary Busin ... | Option Exercise | A | 13.02 | 40,000 | 520,800 | 132,000 | |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | A | 13.02 | 40,000 | 520,800 | 145,000 | |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | General Counsel and ... | Option Exercise | A | 13.02 | 10,500 | 136,710 | 50,400 | |
| Mar 22 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman of the Boa ... | Sell | S | 12.23 | 17,700 | 216,471 | 240,792 | 258.5 K to 240.8 K (-6.85 %) |
| Mar 21 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman of the Boa ... | Option Exercise | D | 0.01 | 8,333 | 83 | 0 | |
| Mar 21 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman of the Boa ... | Option Exercise | D | 0.01 | 25,000 | 250 | 0 | |
| Mar 21 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman of the Boa ... | Option Exercise | D | 0.01 | 18,750 | 188 | 0 | |
| Mar 21 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman of the Boa ... | Grant | A | 0.01 | 52,083 | 521 | 258,492 | 206.4 K to 258.5 K (+25.23 %) |
| Mar 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | D | 0.01 | 2,500 | 25 | 5,500 | |
| Mar 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | D | 0.01 | 12,501 | 125 | 0 | |
| Mar 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Grant | A | 0.01 | 15,001 | 150 | 328,542 | 313.5 K to 328.5 K (+4.78 %) |
| Mar 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | D | 0.01 | 2,500 | 25 | 5,500 | |
| Mar 12 2007 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Grant | A | 0.01 | 2,500 | 25 | 4,600 | 2.1 K to 4.6 K (+119.05 %) |
| Mar 05 2007 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | P | 11.27 | 1,000 | 11,270 | 10,000 | 9 K to 10 K (+11.11 %) |
| Mar 05 2007 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | P | 11.27 | 9,000 | 101,430 | 9,000 | 0 to 9 K |
| Mar 05 2007 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Buy | P | 11.77 | 1,000 | 11,770 | 5,000 | 4 K to 5 K (+25.00 %) |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 8.07 | 1,000 | 8,065 | 0 | |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 14.52 | 1,000 | 14,520 | 1,000 | 0 to 1,000 |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 9.31 | 930 | 8,661 | 0 | |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 9.31 | 13,070 | 121,714 | 0 | |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 13.29 | 930 | 12,360 | 15,000 | 14.1 K to 15 K (+6.61 %) |
| Jan 30 2007 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 13.29 | 13,070 | 173,700 | 14,070 | 1,000 to 14.1 K (+1,307.00 %) |
| Jan 16 2007 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | A | 14.52 | 600,000 | 8,712,000 | 600,000 | |
| Jan 09 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 0.01 | 4,167 | 42 | 61,805 | |
| Jan 09 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 0.01 | 8,333 | 83 | 57,638 | |
| Jan 09 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 15.24 | 12,500 | 190,500 | 947,464 | |
| Jan 09 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 15.24 | 17,000 | 259,080 | 934,964 | |
| Jan 09 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Sell | S | 14.51 | 3,592 | 52,120 | 208,619 | 212.2 K to 208.6 K (-1.69 %) |
| Jan 05 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | D | 0.01 | 8,334 | 83 | 0 | |
| Jan 05 2007 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Grant | A | 0.01 | 8,334 | 83 | 212,211 | 203.9 K to 212.2 K (+4.09 %) |
| Nov 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Buy | P | 14.65 | 1,000 | 14,650 | 4,000 | 3 K to 4 K (+33.33 %) |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 155,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 77,375 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | LERNER IRWIN | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | LERNER IRWIN | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 165,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 120,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 67,500 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | BROWN MICHAEL A/CA | Director | Option Exercise | A | 0.01 | 5,000 | 50 | 5,000 | |
| Sep 22 2006 | NKTR | NEKTAR THERAPEUTIC ... | BROWN MICHAEL A/CA | Director | Option Exercise | A | 14.36 | 15,000 | 215,400 | 122,500 | |
| Sep 06 2006 | NKTR | NEKTAR THERAPEUTIC ... | Elam Nevan C | General Counsel and ... | Option Exercise | A | 17.52 | 12,000 | 210,240 | 92,000 | |
| Sep 06 2006 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | A | 17.52 | 20,000 | 350,400 | 105,000 | |
| Aug 10 2006 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Buy | P | 16.35 | 1,000 | 16,350 | 3,000 | 2 K to 3 K (+50.00 %) |
| Jun 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 0.01 | 25,000 | 250 | 57,639 | |
| Jun 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Chairman, Pres. & C ... | Option Exercise | A | 18.34 | 50,000 | 917,000 | 917,964 | |
| May 18 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 20.21 | 1,633 | 33,003 | 614 | 2.2 K to 614 (-72.67 %) |
| May 15 2006 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Buy | P | 20.35 | 1,000 | 20,350 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.62 | 760 | 14,911 | 87,991 | 88.8 K to 88 K (-0.86 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.60 | 1,085 | 21,266 | 88,751 | 89.8 K to 88.8 K (-1.21 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.59 | 100 | 1,959 | 89,836 | 89.9 K to 89.8 K (-0.11 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.58 | 200 | 3,916 | 89,936 | 90.1 K to 89.9 K (-0.22 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.63 | 500 | 9,815 | 90,136 | 90.6 K to 90.1 K (-0.55 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.61 | 600 | 11,766 | 90,636 | 91.2 K to 90.6 K (-0.66 %) |
| Mar 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 19.64 | 300 | 5,892 | 91,236 | 91.5 K to 91.2 K (-0.33 %) |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | A | 19.90 | 15,000 | 298,500 | 85,000 | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | Elam Nevan C | General Counsel and ... | Option Exercise | A | 0.01 | 7,000 | 70 | 7,000 | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | A | 0.01 | 15,000 | 150 | 45,834 | |
| Mar 09 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Option Exercise | D | 0.01 | 8,333 | 83 | 20,501 | ||
| Mar 09 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Grant | A | 0.01 | 8,333 | 83 | 10,333 | 2 K to 10.3 K (+416.65 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.01 | 300 | 6,003 | 5,166 | 5.5 K to 5.2 K (-5.49 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.88 | 500 | 9,940 | 5,466 | 6 K to 5.5 K (-8.38 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.89 | 1,000 | 19,890 | 5,966 | 7 K to 6 K (-14.36 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.98 | 800 | 15,984 | 6,966 | 7.8 K to 7 K (-10.30 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.85 | 100 | 1,985 | 7,766 | 7.9 K to 7.8 K (-1.27 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.90 | 300 | 5,970 | 7,866 | 8.2 K to 7.9 K (-3.67 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.92 | 300 | 5,976 | 8,166 | 8.5 K to 8.2 K (-3.54 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.97 | 100 | 1,997 | 8,466 | 8.6 K to 8.5 K (-1.17 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.00 | 400 | 8,000 | 8,566 | 9 K to 8.6 K (-4.46 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.86 | 600 | 11,916 | 8,966 | 9.6 K to 9 K (-6.27 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.87 | 467 | 9,279 | 9,566 | 10 K to 9.6 K (-4.65 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 19.94 | 200 | 3,988 | 10,033 | 10.2 K to 10 K (-1.95 %) | |
| Mar 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Sell | S | 20.04 | 100 | 2,004 | 10,233 | 10.3 K to 10.2 K (-0.97 %) | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Option Exercise | D | 0.01 | 2,000 | 20 | 28,834 | ||
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | Grant | A | 0.01 | 2,000 | 20 | 2,000 | 0 to 2 K | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 0.01 | 5,555 | 56 | 8,334 | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Sell | S | 19.80 | 2,210 | 43,748 | 201,667 | 203.9 K to 201.7 K (-1.08 %) |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Grant | A | 0.01 | 5,555 | 56 | 203,877 | 198.3 K to 203.9 K (+2.80 %) |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | D | 0.01 | 10,333 | 103 | 20,501 | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 19.80 | 3,859 | 76,390 | 558,131 | 562 K to 558.1 K (-0.69 %) |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Grant | A | 0.01 | 10,333 | 103 | 561,990 | 551.7 K to 562 K (+1.87 %) |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Option Exercise | D | 0.01 | 2,000 | 20 | 8,000 | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | Johnston David | SVP, Research & Dev ... | Grant | A | 0.01 | 2,000 | 20 | 2,100 | 100 to 2.1 K (+2,000.00 %) |
| Mar 03 2006 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Buy | P | 20.08 | 1,000 | 20,080 | 1,000 | 0 to 1,000 |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | D | 0.01 | 10,000 | 100 | 81,667 | |
| Mar 07 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Grant | A | 0.01 | 10,000 | 100 | 91,536 | 81.5 K to 91.5 K (+12.26 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.11 | 700 | 15,477 | 81,536 | 82.2 K to 81.5 K (-0.85 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.10 | 600 | 13,261 | 82,236 | 82.8 K to 82.2 K (-0.72 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.10 | 1,400 | 30,940 | 82,836 | 84.2 K to 82.8 K (-1.66 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.09 | 3,900 | 86,165 | 84,236 | 88.1 K to 84.2 K (-4.42 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.09 | 2,400 | 53,015 | 88,136 | 90.5 K to 88.1 K (-2.65 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.08 | 1,000 | 22,076 | 90,536 | 91.5 K to 90.5 K (-1.09 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.07 | 13,300 | 293,583 | 91,536 | 104.8 K to 91.5 K (-12.69 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 22.06 | 16,700 | 368,402 | 104,836 | 121.5 K to 104.8 K (-13.74 %) |
| Feb 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | A | 0.01 | 18,750 | 188 | 32,639 | |
| Feb 24 2006 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | A | 21.50 | 37,500 | 806,250 | 867,964 | |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 5.06 | 23,355 | 118,235 | 0 | |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 5.06 | 16,645 | 84,265 | 0 | |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | M | 5.06 | 18,000 | 91,125 | 0 | |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 19.37 | 23,355 | 452,386 | 571,657 | 548.3 K to 571.7 K (+4.26 %) |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 19.32 | 16,645 | 321,581 | 548,302 | 531.7 K to 548.3 K (+3.13 %) |
| Jan 20 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Buy | M | 19.32 | 18,000 | 347,760 | 531,657 | 513.7 K to 531.7 K (+3.50 %) |
| Jan 30 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 22.00 | 20,000 | 440,000 | 551,657 | 571.7 K to 551.7 K (-3.50 %) |
| Jan 19 2006 | NKTR | NEKTAR THERAPEUTIC ... | DRAPEAU LOUIS | Sr. VP Finance, CFO | Option Exercise | A | 20.00 | 90,000 | 1,800,000 | 0 | |
| Jan 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | M | 5.06 | 6,374 | 32,268 | 0 | |
| Jan 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | M | 5.06 | 7,334 | 37,128 | 0 | |
| Jan 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | M | 5.06 | 9,776 | 49,491 | 0 | |
| Jan 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | M | 5.06 | 19,626 | 99,357 | 0 | |
| Jan 13 2006 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Buy | M | 18.29 | 43,110 | 788,482 | 121,226 | 78.1 K to 121.2 K (+55.19 %) |
| Jan 04 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Gift | G | 0.00 | 3,900 | 0 | 533,657 | 537.6 K to 533.7 K (-0.73 %) |
| Jan 17 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 20.07 | 8,400 | 168,588 | 513,657 | 522.1 K to 513.7 K (-1.61 %) |
| Jan 17 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 20.08 | 1,600 | 32,128 | 522,057 | 523.7 K to 522.1 K (-0.31 %) |
| Jan 17 2006 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 20.00 | 10,000 | 200,000 | 523,657 | 533.7 K to 523.7 K (-1.87 %) |
| Dec 14 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Gift | G | 0.00 | 8,329 | 0 | 78,116 | 86.4 K to 78.1 K (-9.64 %) |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | WHITFIELD ROY A | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 140,000 | |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | LERNER IRWIN | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 150,000 | |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | WANG SUSAN | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 62,375 | |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 42,500 | |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | KUEBLER CHRISTOPHER A | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 105,000 | |
| Sep 19 2005 | NKTR | NEKTAR THERAPEUTIC ... | BROWN MICHAEL A/CA | Director | Option Exercise | A | 17.98 | 12,500 | 224,750 | 107,500 | |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 20.06 | 9,900 | 198,594 | 116,445 | 126.3 K to 116.4 K (-7.84 %) |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 20.17 | 100 | 2,017 | 116,445 | 116.5 K to 116.4 K (-0.09 %) |
| Sep 12 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 21.10 | 10,182 | 214,840 | 86,445 | 96.6 K to 86.4 K (-10.54 %) |
| Sep 12 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 21.16 | 9,450 | 199,962 | 86,445 | 95.9 K to 86.4 K (-9.85 %) |
| Sep 12 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Sell | S | 21.25 | 10,368 | 220,320 | 86,445 | 96.8 K to 86.4 K (-10.71 %) |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 5.43 | 3,000 | 16,287 | 95,500 | |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 19.96 | 3,000 | 59,880 | 0 | 3 K to 0 (-100.00 %) |
| Sep 07 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Buy | M | 5.43 | 3,000 | 16,287 | 0 | -3,000 to 0 (-100.00 %) |
| Jun 02 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | D | 0.00 | 8,333 | 0 | 41,667 | |
| Jun 02 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Grant | A | 0.00 | 8,333 | 0 | 126,445 | 118.1 K to 126.4 K (+7.06 %) |
| Jun 02 2005 | NKTR | NEKTAR THERAPEUTIC ... | BROWN MICHAEL A/CA | Director | Option Exercise | A | 18.19 | 30,000 | 545,700 | 95,000 | |
| Jun 02 2005 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 18.19 | 30,000 | 545,700 | 40,000 | |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Option Exercise | D | 0.00 | 4,166 | 0 | 30,834 | |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Sell | S | 16.41 | 4,166 | 68,384 | 0 | 4.2 K to 0 (-100.00 %) |
| May 17 2005 | NKTR | NEKTAR THERAPEUTIC ... | BANSAL AJAY | CFO, VP Finance & A ... | Grant | A | 0.00 | 4,166 | 0 | 4,166 | 0 to 4.2 K |
| May 10 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 14.47 | 1,750 | 25,323 | 1,621 | 3.4 K to 1.6 K (-51.91 %) |
| Mar 23 2005 | NKTR | NEKTAR THERAPEUTIC ... | Krivulka Joseph J | Director | Option Exercise | A | 13.46 | 10,000 | 134,600 | 10,000 | |
| Mar 16 2005 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Option Exercise | D | 0.00 | 2,777 | 0 | 13,889 | |
| Mar 16 2005 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Executive Chairman | Grant | A | 0.00 | 2,777 | 0 | 207,765 | 205 K to 207.8 K (+1.35 %) |
| Mar 16 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Option Exercise | D | 0.00 | 4,166 | 0 | 30,834 | |
| Mar 16 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Sell | S | 14.37 | 1,487 | 21,368 | 534,878 | 536.4 K to 534.9 K (-0.28 %) |
| Mar 16 2005 | NKTR | NEKTAR THERAPEUTIC ... | PATTON JOHN STUART | Chief Scientific Of ... | Grant | A | 0.00 | 4,166 | 0 | 539,044 | 534.9 K to 539 K (+0.78 %) |
| Feb 14 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | A | 0.01 | 50,000 | 500 | 100,000 | |
| Feb 14 2005 | NKTR | NEKTAR THERAPEUTIC ... | GILL AJIT | President & CEO | Option Exercise | A | 18.08 | 125,000 | 2,260,000 | 1,580,400 |